Federated Hermes, Inc. Black Diamond Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.67 - $5.74 $6,837 - $14,700	-2,561 Reduced 95.99%	107 $0
Q4 2023 Jan 31, 2024	SELL	$1.77 - $3.03 $4,421 - $7,568	-2,498 Reduced 48.35%	2,668 $7,000
Q3 2023 Nov 13, 2023	BUY	$2.87 - $4.99 $344 - $598	120 Added 2.38%	5,166 $14,000
Q2 2023 Aug 14, 2023	SELL	$1.43 - $6.18 $11,638 - $50,299	-8,139 Reduced 61.73%	5,046 $25,000
Q1 2023 May 08, 2023	SELL	$1.35 - $3.14 $191,745 - $445,986	-142,034 Reduced 91.51%	13,185 $24,000
Q4 2022 Feb 13, 2023	SELL	$1.27 - $2.51 $5,497 - $10,865	-4,329 Reduced 2.71%	155,219 $279,000
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.63 $1.31 Million - $3.18 Million	-875,587 Reduced 84.59%	159,548 $392,000
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $1.35 Million - $1.98 Million	159,183 Added 18.17%	1,035,135 $8.76 Million
Q1 2021 May 13, 2021	BUY	$22.23 - $34.75 $6.13 Million - $9.59 Million	275,952 Added 45.99%	875,952 $21.3 Million
Q4 2020 Feb 12, 2021	BUY	$29.47 - $35.0 $3.69 Million - $4.38 Million	125,273 Added 26.39%	600,000 $19.2 Million
Q2 2020 Aug 13, 2020	BUY	$22.3 - $44.8 $1.67 Million - $3.35 Million	74,727 Added 18.68%	474,727 $20 Million
Q1 2020 May 13, 2020	BUY	$18.18 - $39.48 $7.27 Million - $15.8 Million	400,000 New	400,000 $9.98 Million

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $90.5M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.